• Development of novel solid forms of API e.g. Polymorphs, solvates, co-crystals, co-amorphous, eutectic mixtures etc. Solid State Characterization of API

• Particle engineering for better biopharmaceutical properties

• Crystal engineering for improving mechanical properties such as tabletability, flow properties, CTC etc.